Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONIA: Isoniazid for Ischemic Leg Ulcers
NCT04802928Phase 2Withdrawn
- Sponsor
- Pharma 2100
- Start
- Apr 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isoniazid in Ischemic ulcer, sponsored by Pharma 2100. Planned start Apr 2008; status: withdrawn.
02
Drugs
isoniazid
03
Conditions
Ischemic ulcer
Beyond the preview
Go deeper on NCT04802928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04802928.